Safeguarding the quality of medication is fundamental to protecting the public’s health, especially as ingredients and products come from all over the world. Biologics — such as recombinant therapeutic proteins, vaccines, blood components, tissues and gene therapies — are growing faster than any other segment of medicine. Just as they do for chemical medicines, manufacturers must ensure the purity and quality of the biologics that make their way to patients. USP quality standards serve as the foundation for a robust safety network that assists manufacturers by increasing predictability and reliability, and preserving the integrity of the global supply chain.
Join the Conversation about Raw Materials
and Performance Standards!
What non-product-specific reference standards
do you need?
7th Bioassay Workshop—Bioassay:
A Lifecycle Approach
September 25-26, 2017
Join in discussion of scientific, statistical,
and regulatory perspectives of lifecycle methods.
4th Workshop on Synthetic
November 6-7, 2017
Don’t miss this opportunity to learn about
GMP manufacturing considerations,
analytical characterizations, CMC
and formulation for diverse delivery
systems, and USP updates.